Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy

NCT06817265 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Proliferative Diabetic Retinopathy

Interventions

DRUG: TNTL
DRUG: TNTL simulation preparation

Sponsor

Beletalent (Zhuhai) Pharmaceutical Co., Ltd